Edition:
United Kingdom

Ascendis Health Ltd (ASCJ.J)

ASCJ.J on Johannesburg Stock Exchange

486.00ZAc
20 May 2019
Change (% chg)

-14.00 (-2.80%)
Prev Close
500.00
Open
470.00
Day's High
486.00
Day's Low
470.00
Volume
124,764
Avg. Vol
916,163
52-wk High
1,200.00
52-wk Low
305.00

Latest Key Developments (Source: Significant Developments)

Ascendis Health Says John A Bester Has Retired From Board As Chairman
Friday, 3 May 2019 

May 3 (Reuters) - Ascendis Health Ltd ::ASCENDIS HEALTH LTD - JOHN A BESTER HAS RETIRED FROM BOARD AS CHAIRMAN.ASCENDIS HEALTH LTD - ANDREW B MARSHALL HAS BEEN APPOINTED TO BOARD AS CHAIRMAN.  Full Article

Ascendis Health Announces Disposal Of Afrikelp, Efekto And Marltons Businesses Within The Co's Biosciences Division
Thursday, 2 May 2019 

May 2 (Reuters) - Ascendis Health Ltd ::JSE: ASC - DISPOSAL OF AFRIKELP, EFEKTO AND MARLTONS BUSINESSES WITHIN THE ASCENDIS BIOSCIENCES DIVISION.ASCENDIS HEALTH LTD - TOTAL CONSIDERATION PAYABLE TO CO FOR DISPOSAL BUSINESSES IS A BASE PRICE OF R480 MILLION.ASCENDIS HEALTH - GOT INTO AGREEMENTS WITH CONSORTIUM OF RMB VENTURES SEVEN PROPRIETARY, NEDBANK PRIVATE EQUITY.ASCENDIS HEALTH - AVIMA PROPRIETARY LIMITED AND KLUB M5 PROPRIETARY LIMITED MAY BE CONSIDERED FOR DIVESTMENT IN SHORT TO MEDIUM TERM.ASCENDIS HEALTH LTD - ASCENDIS BIOSCIENCES DIVISION WILL BE RESTRUCTURED AND DISPOSED OF TRANSACTION.ASCENDIS HEALTH - CASH PROCEEDS FROM TRANSACTION WILL BE APPLIED TO REDUCE DEBT LEVELS AND FUND WORKING CAPITAL.  Full Article

Ascendis Health Discloses Details On HY 2017 Results Restatement
Friday, 15 Mar 2019 

March 15 (Reuters) - Ascendis Health Ltd ::ASCENDIS HEALTH- HY 2017 RESTATEMENT ON MAR. 8 RELATING TO TOTAL OPERATIONS EPS, HEPS WAS RESULT OF INTERCOMPANY PROFIT IN INVENTORY NOT ELIMINATED.ASCENDIS HEALTH LTD - COST OF SALES AND INVENTORY AS AT 31 DECEMBER 2017 HAVE THEREFORE BEEN RESTATED IN TERMS OF IAS 8.ASCENDIS HEALTH LTD - HY 2017 RESTATEMENT RESULTED IN A DECREASE IN BASIC AND DILUTED EARNINGS PER SHARE OF 5.5 CENTS.ASCENDIS HEALTH LTD - ALL INTERCOMPANY PROFIT IN RESPECT OF INVENTORY ELIMINATIONS HAVE ALREADY BEEN RECORDED FOR YEAR ENDED 30 JUNE 2018.  Full Article

Ascendis Health Sees FY Total Operations Normalised HEPS 132.3 - 138.8 Cents
Friday, 7 Sep 2018 

Sept 7 (Reuters) - Ascendis Health Ltd ::POSTPONEMENT OF RELEASE OF ANNUAL RESULTS AND VOLUNTARY TRADING STATEMENT.SEES FY HEPS 102.7 - 109.2 CENTS.FY RESULTS SCHEDULED TO BE RELEASED ON 11 SEPTEMBER 2018, WILL NOW BE RELEASED ON ON 25 SEPTEMBER 2018.POSTPONEMENT DUE TO DELAYS IN FINALISING RESULTS FOLLOWING IMPLEMENTATION OF NEW FINANCIAL REPORTING SYSTEM LATE IN FINANCIAL YEAR.SEES FY TOTAL OPERATIONS NORMALISED HEPS 132.3 - 138.8 CENTS.ASCENDIS HEALTH LTD SEES FY TOTAL OPERATIONS HEPS 74.5 - 81.0 CENTS.  Full Article

Ascendis Health appoints Thomas Thomsen as CEO with effect from 1 March 2018
Tuesday, 27 Feb 2018 

Feb 27 (Reuters) - Ascendis Health Ltd ::ANNOUNCE APPOINTMENT OF THOMAS THOMSEN AS CHIEF EXECUTIVE OFFICER AND AS AN EXECUTIVE DIRECTOR WITH EFFECT FROM 1 MARCH 2018.THOMAS WILL SUCCEED KARSTEN WELLNER WHO HAS BEEN THE CEO SINCE THE FOUNDING OF THE GROUP IN 2011.‍KARSTEN WILL STAND DOWN AS CEO ON 1 MARCH 2018 AND AS A BOARD DIRECTOR ON 30 JUNE 2018​.  Full Article

Ascendis Health Sees ‍HY HEPS Of 52 - 55 Cents​
Wednesday, 31 Jan 2018 

Jan 31 (Reuters) - Ascendis Health Ltd ::SEES HY HEADLINE EARNINGS PER SHARE OF 52 - 55 CENTS​.  Full Article

Ascendis Health announces acquisition of Kyron Laboratories Proprietary Ltd​
Tuesday, 28 Nov 2017 

Nov 28 (Reuters) - Ascendis Health Ltd ::‍ACQUISITION OF 100% OF KYRON LABORATORIES PROPRIETARY LIMITED​.DEAL ‍FOR A CONSIDERATION OF R396.4 MILLION UPFRONT PLUS A PERFORMANCE-BASED DEFERRED PORTION FROM NIXSIM PROPRIETARY LIMITED​.‍PURCHASE CONSIDERATION IS LIMITED TO A MAXIMUM OF R450 MILLION​.  Full Article

Ascendis Health says fully underwritten renounceable rights offer of 750 mln rand at 20.00 rand per share​
Tuesday, 21 Nov 2017 

Nov 21 (Reuters) - Ascendis Health Ltd :‍BOARD HAS RESOLVED TO UNDERTAKE A FULLY UNDERWRITTEN RIGHTS OFFER TO RAISE APPROXIMATELY R750 MILLION TO FUND ACCELERATED PAYMENT.​.‍RIGHTS OFFER IS FULLY UNDERWRITTEN BY A WHOLLY OWNED SUBSIDIARY OF MAJOR SHAREHOLDER, COAST2COAST CAPITAL PROPRIETARY LIMITED​.FULLY UNDERWRITTEN RENOUNCEABLE RIGHTS OFFER OF 750 MILLION RAND AT 20.00 RAND PER SHARE​.  Full Article

Ascendis Health announces ‍transaction update relating to acquisition of Remedica​
Monday, 13 Nov 2017 

Nov 13 (Reuters) - ASCENDIS HEALTH LTD ::‍TRANSACTION UPDATE RELATING TO ASCENDIS' ACQUISITION OF REMEDICA​.‍BOARD HAS RESOLVED TO RAISE EQUITY TO REPAY PORTION OF CO'S MEDIUM TERM DEBT OBLIGATIONS IN ORDER TO REDUCE ITS DEBT POSITION​.‍BOARD ELECTED TO SETTLE A PORTION OF DEFERRED PAYMENT IN ADVANCE OF ITS DUE DATE​.  Full Article

Ascendis Health intends to raise about 750 mln rand in rights offering​
Wednesday, 1 Nov 2017 

Nov 1 (Reuters) - Ascendis Health Ltd :‍COMPANY INTENDS TO RAISE APPROXIMATELY 750 MILLION RAND IN RIGHTS OFFERING​.‍PROCEEDS WILL BE USED TO SETTLE A SIGNIFICANT PORTION OF OUTSTANDING DEFERRED VENDOR CONSIDERATION PAYMENTS​.‍ANTICIPATED THAT RIGHTS OFFER SHARES WILL BE OFFERED AT A PREMIUM TO CURRENT MARKET PRICE​.  Full Article

Deals of the day-Mergers and acquisitions

May 2 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Thursday: